Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Failure to establish and maintain procedures for implementing corrective and preventive actions, as required by 820.100(a). Specifically, your Corrective Action and Preventive Action, Procedure No. S100016-03, Rev E. Dated January 30, 2023, is inadequate in that:
Passage 2Failure to document all activities and their results required under this section (Corrective and preventive action) as required by 21 CFR 820.100(b). Specifically:
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 806
- 21 CFR 806.10(b)
- 21 CFR 820.100(b)
- 21 CFR 820.30(g)